GYRE THERAPEUTICS INC. (GYRE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-18
06:12 am
Purchase
2022-01-1313GCATALYST BIOSCIENCES INC N
CBIO
Assenagon Asset Management S.A.18,769
5.980%
7,623increase
(+68.39%)
Filing
History
2022-01-05
5:29 pm
Purchase
2022-01-0413DCATALYST BIOSCIENCES INC N
CBIO
SINGER JULIAN D.7,804
2.480%
1,200increase
(+18.17%)
Filing
History
2021-10-25
9:08 pm
Purchase
2021-10-2513DCATALYST BIOSCIENCES INC N
CBIO
SINGER JULIAN D.6,604
2.110%
2,616increase
(+65.60%)
Filing
History
Goto Prev, 0, 1, 2